|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 14-11-03 | Covance : Dow, S&P 500 close slightly lower; semis boost Nasdaq | RE |
| 14-11-03 | Covance : LabCorp to pay $6.1 billion for drug trial company Covance | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | - | 2023-03-05 | |
Hong Gang Bi
PRN | Corporate Officer/Principal | 67 | 2011-05-30 |
Stephen Street
PRN | Corporate Officer/Principal | 65 | 2012-06-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Glenn Eisenberg
BRD | Director/Board Member | 64 | 2015-02-18 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.65% | -3.56% | +33.53% | +60.50% | 63.48B | |
| +2.66% | +2.16% | +12.80% | +83.72% | 54.55B | |
| -0.87% | +0.99% | +10.45% | +102.18% | 53.59B | |
| +2.90% | +1.10% | +28.22% | +57.87% | 44.75B | |
| +2.56% | -3.02% | +18.29% | +100.85% | 41.62B | |
| +1.16% | -3.33% | +222.87% | +923.51% | 39.91B | |
| +0.64% | -3.85% | +11.71% | +45.57% | 32.47B | |
| +30.25% | +45.65% | +104.34% | +91.66% | 26.7B | |
| +3.72% | -7.45% | +24.25% | -2.99% | 23.36B | |
| Average | +4.89% | -0.42% | +51.83% | +162.54% | 42.27B | |
| Weighted average by Cap. | +3.56% | -0.29% | +47.42% | +161.36% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
